Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine Zukotynski, Steven P. Rowe, Amanda L. Blackford et al.|Journal of Nuclear Medicine|2021Cited by 52